Tilmicosin has a broad-spectrum antibacterial effect and has inhibitory effects on Gram positive bacteria, certain negative bacteria, mycoplasma, spirochetes, etc; It has stronger antibacterial activity against Actinobacteria pleuropneumoniae, Pasteurella, and Mycoplasma animalis than Tylosin. Timicozin has fast absorption when taken orally, a large apparent distribution volume, high drug concentration in lung tissue, a half-life of up to 2 days, and a long maintenance time in the body.

1. Mainly used for the prevention and treatment of respiratory diseases caused by sensitive bacteria and mycoplasma. Such as porcine wheezing disease, hemophilus parahaemolyticus disease, pleura, various types of streptococci, actinomycosis, porcine pulmonary disease, respiratory disease syndrome, and chronic respiratory diseases in poultry.
2. It has a good therapeutic effect on concurrent or secondary respiratory infections caused by swine influenza, blue ear disease, circovirus disease, and epidemic unknown high fever.